Relationship Between a Frailty-Related Phenotype and Progressive Deterioration of the Immune System in HIV-Infected Men
暂无分享,去创建一个
[1] R. Varadhan,et al. Opinion section on frailty , 2008, Mechanisms of Ageing and Development.
[2] V. Appay,et al. Immune activation and inflammation in HIV‐1 infection: causes and consequences , 2008, The Journal of pathology.
[3] J. Margolick,et al. HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. , 2007, The journals of gerontology. Series A, Biological sciences and medical sciences.
[4] W. Ershler. A gripping reality: oxidative stress, inflammation, and the pathway to frailty. , 2007, Journal of applied physiology.
[5] L. Fried,et al. Inflammation and Frailty in Older Women , 2007, Journal of the American Geriatrics Society.
[6] B. Autran,et al. Accelerated immune senescence and HIV-1 infection , 2007, Experimental Gerontology.
[7] L. Ferrucci,et al. Frailty of older age: the role of the endocrine--immune interaction. , 2006, Current pharmaceutical design.
[8] S. Studenski,et al. Research Agenda for Frailty in Older Adults: Toward a Better Understanding of Physiology and Etiology: Summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults , 2006, Journal of the American Geriatrics Society.
[9] L. Ferrucci,et al. Phenotype of frailty: characterization in the women's health and aging studies. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.
[10] R. Greenblatt,et al. Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984–2004 , 2005, AIDS.
[11] Luigi Ferrucci,et al. From bedside to bench: research agenda for frailty. , 2005, Science of aging knowledge environment : SAGE KE.
[12] C. Rinaldo,et al. Proinflammatory cytokines in HIV disease-a review and rationale for new therapeutic approaches. , 2005, AIDS reviews.
[13] Jerome H. Kim,et al. HIV-associated wasting in the era of highly active antiretroviral therapy: a syndrome of residual HIV infection in monocytes and macrophages? , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] L. Ferrucci,et al. Impact of anemia and cardiovascular disease on frailty status of community-dwelling older women: the Women's Health and Aging Studies I and II. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.
[15] G. Pawelec,et al. Human immunosenescence: is it infectious? , 2005, Immunological reviews.
[16] R. Effros,et al. The role of CD8+ T‐cell replicative senescence in human aging , 2005, Discovery medicine.
[17] L. Fried,et al. Chronic Cytomegalovirus Infection and Inflammation Are Associated with Prevalent Frailty in Community‐Dwelling Older Women , 2005, Journal of the American Geriatrics Society.
[18] J. Margolick,et al. T cell subsets and mortality in older community-dwelling women , 2005, Experimental Gerontology.
[19] F. Miedema,et al. Significance of senescence for virus-specific memory T cell responses: rapid ageing during chronic stimulation of the immune system. , 2005, Immunology letters.
[20] C. Franceschi,et al. Chronic antigenic load and apoptosis in immunosenescence. , 2005, Trends in immunology.
[21] G. Mcgwin,et al. Factors associated with chronic renal failure in HIV-infected ambulatory patients , 2004, AIDS.
[22] J. Phair,et al. Update on the virologic and immunologic response to highly active antiretroviral therapy , 2004, Current infectious disease reports.
[23] Bruce M Psaty,et al. The presence of frailty in elderly persons with chronic renal insufficiency. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[24] L. Lipsitz. Physiological complexity, aging, and the path to frailty. , 2004, Science of aging knowledge environment : SAGE KE.
[25] A. Vallejo,et al. T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection. , 2004, Trends in molecular medicine.
[26] J. Walston,et al. Frailty--the search for underlying causes. , 2004, Science of aging knowledge environment : SAGE KE.
[27] R. Westendorp,et al. Lymphocyte Count and Mortality Risk in Older Persons. The Leiden 85‐Plus Study , 2003, Journal of the American Geriatrics Society.
[28] W. Hazzard,et al. Principles of Geriatric Medicine and Gerontology , 2003 .
[29] M. Lederman,et al. Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumes. , 2003, The Journal of infectious diseases.
[30] G. Pawelec,et al. Basic biology and clinical impact of immunosenescence , 2003, Biogerontology.
[31] M. Schroll,et al. Predicting death from tumour necrosis factor‐alpha and interleukin‐6 in 80‐year‐old people , 2003, Clinical and experimental immunology.
[32] G. Martínez,et al. Contribution to characterization of oxidative stress in HIV/AIDS patients. , 2003, Pharmacological research.
[33] B. Pedersen,et al. Age-related inflammatory cytokines and disease. , 2003, Immunology and allergy clinics of North America.
[34] Helle Bruunsgaard,et al. Effects of tumor necrosis factor-alpha and interleukin-6 in elderly populations. , 2003, European cytokine network.
[35] Suzanne G. Leveille,et al. Change in Muscle Strength Explains Accelerated Decline of Physical Function in Older Women With High Interleukin‐6 Serum Levels , 2002, Journal of the American Geriatrics Society.
[36] S. Rowland-Jones,et al. Premature ageing of the immune system: the cause of AIDS? , 2002, Trends in immunology.
[37] Mark Dybul,et al. Guidelines for Using Antiretroviral Agents among HIV-Infected Adults and Adolescents: The Panel on Clinical Practices for Treatment of HIV* , 2002, Annals of Internal Medicine.
[38] J W Rowe,et al. Interleukin-6 and risk of cognitive decline: MacArthur Studies of Successful Aging , 2002, Neurology.
[39] A. Dobs,et al. Changes in the incidence and predictors of wasting syndrome related to human immunodeficiency virus infection, 1987-1999. , 2002, American journal of epidemiology.
[40] G. Wittert,et al. The low dose dexamethasone suppression test: Effect of time of administration and dose , 2002, Journal of endocrinological investigation.
[41] M. Hernán,et al. Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. , 2002, American journal of epidemiology.
[42] J. Margolick,et al. Increase and plateau of CD4 T-cell counts in the 3(1/2) years after initiation of potent antiretroviral therapy. , 2001 .
[43] R. Effros. Long-term immunological memory against viruses , 2001, Mechanisms of Ageing and Development.
[44] R. Effros,et al. Ageing of lymphocytes and lymphocytes in the aged. , 2000, Immunology today.
[45] J. Rabkin,et al. Psychological Effects of HAART: A 2-Year Study , 2000, Psychosomatic medicine.
[46] P Royston,et al. The use of fractional polynomials to model continuous risk variables in epidemiology. , 1999, International journal of epidemiology.
[47] L. Fried,et al. Frailty and the older man. , 1999, The Medical clinics of North America.
[48] Luigi Ferrucci,et al. Serum IL‐6 Level and the Development of Disability in Older Persons , 1999, Journal of the American Geriatrics Society.
[49] A Muñoz,et al. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators. , 1998, JAMA.
[50] B. Johansson,et al. Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: the Swedish longitudinal OCTO-immune study , 1998, Mechanisms of Ageing and Development.
[51] C. Gibert,et al. Weight loss as a predictor of survival and disease progression in HIV infection. Terry Beirn Community Programs for Clinical Research on AIDS. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[52] S. Grinspoon,et al. Diagnosis and treatment of endocrine disorders in the HIV-infected patient. , 1998, Journal of the International Association of Physicians in AIDS Care.
[53] M. Gougerot-Pocidalo,et al. Oxidative stress in human immunodeficiency virus infection , 1997, Cellular and Molecular Life Sciences CMLS.
[54] J. Rabkin,et al. A 'second life' agenda. Psychiatric research issues raised by protease inhibitor treatments for people with the human immunodeficiency virus or the acquired immunodeficiency syndrome. , 1997, Archives of general psychiatry.
[55] K. Kreuzer,et al. Pathogenesis and pathophysiology of anemia in HIV infection , 1997, Annals of Hematology.
[56] D M Buchner,et al. Unstable disability and the fluctuations of frailty. , 1997, Age and ageing.
[57] I. Rea,et al. Changes in lymphocyte subsets, interleukin 2, and soluble interleukin 2 receptor in old and very old age. , 1996, Gerontology.
[58] C. Harley,et al. Shortened telomeres in the expanded CD28-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. , 1996, AIDS.
[59] D. Rubin. Multiple Imputation After 18+ Years , 1996 .
[60] S. Levinson,et al. Focused review: physiatric management of HIV-related disability. , 1996, Archives of physical medicine and rehabilitation.
[61] L. Kingsley,et al. Weight loss prior to clinical AIDS as a predictor of survival. Multicenter AIDS Cohort Study Investigators. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[62] J. Chmiel,et al. The Multicenter AIDS Cohort Study: retention after 9 1/2 years. , 1995, American journal of epidemiology.
[63] J. Margolick,et al. Failure of T-cell homeostasis preceding AIDS in HIV-1 infection , 1995, Nature Medicine.
[64] M. Loveless,et al. The HIV wasting syndrome: a review. , 1994, Journal of acquired immune deficiency syndromes.
[65] N. Liabakk,et al. Serum Levels of Tumor Necrosis Factor-α (TNFα) and Soluble TNF Receptors in Human Immunodeficiency Virus Type 1 Infection-Correlations to Clinical, Immunologic, and Virologic Parameters , 1994 .
[66] J. Phair,et al. Changes in survival after acquired immunodeficiency syndrome (AIDS): 1984-1991. , 1993, American journal of epidemiology.
[67] John W. Ward,et al. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. , 1993, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[68] J. Bilezikian,et al. HIV disease and the endocrine system. , 1992, The New England journal of medicine.
[69] J. Margolick,et al. Relationship between the immune system and frailty: Pathogenesis of immune deficiency in HIV infection and aging , 1992, Aging.
[70] L. Fried. Conference on the physiologic basis of frailty. April 28, 1992, Baltimore, Maryland, U.S.A. Introduction. , 1992, Aging.
[71] C. Sherbourne,et al. The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .
[72] A. Lazzarin,et al. Elevated alpha–tumor necrosis factor levels in spinal fluid from HIV‐1–infected patients with central nervous system involvement , 1991, Annals of neurology.
[73] R. Redfield,et al. Induction of interleukin-6 during human immunodeficiency virus infection. , 1990, Blood.
[74] G. Beall,et al. Infection with HIV is associated with elevated IL-6 levels and production. , 1990, Journal of immunology.
[75] J. Phair,et al. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. , 1987, American journal of epidemiology.
[76] K Y Liang,et al. Longitudinal data analysis for discrete and continuous outcomes. , 1986, Biometrics.
[77] B. Armstrong,et al. BREAST CANCER AND SPIRONOLACTONE , 1975, The Lancet.
[78] I. Mackay,et al. Ageing, immune response, and mortality. , 1974, Lancet.
[79] K. Manton,et al. The immune system in aging: roles of cytokines, T cells and NK cells. , 2005, Frontiers in bioscience : a journal and virtual library.
[80] M. Leal,et al. CD4+ T-lymphocytopenia in the elderly , 2005, European Journal of Clinical Microbiology and Infectious Diseases.
[81] S. Bandinelli,et al. Biomarkers of frailty in older persons. , 2002, Journal of endocrinological investigation.
[82] L. Fried,et al. Frailty in older adults: evidence for a phenotype. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.
[83] E. Keller,et al. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. , 2000, Annual review of medicine.
[84] W. Strawbridge,et al. Antecedents of frailty over three decades in an older cohort. , 1998, The journals of gerontology. Series B, Psychological sciences and social sciences.
[85] N. Liabakk,et al. Serum levels of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection--correlations to clinical, immunologic, and virologic parameters. , 1994, The Journal of infectious diseases.
[86] C. Sherbourne,et al. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. , 1994 .
[87] Ware J.E.Jr.,et al. THE MOS 36- ITEM SHORT FORM HEALTH SURVEY (SF- 36) CONCEPTUAL FRAMEWORK AND ITEM SELECTION , 1992 .
[88] L. Radloff. The CES-D Scale: A Self-Report Depression Scale for Research in the General Population — Source link , 2022 .